Jan 11, 2017 9:44am EST CohBar, Inc. Announces Expiration of Warrants and Reports Aggregate Proceeds from Warrant Exercises
Jan 10, 2017 8:06pm EST CohBar, Inc.’s CEO Simon Allen to Present at the 9th Annual Biotech Showcase in San Francisco
Dec 06, 2016 9:00am EST CohBar, Inc. Continues Exploration of Mitochondrial Genome and Expansion of Its IP Portfolio with Filing of 29 New Provisional Patents
Sep 30, 2016 9:00am EDT CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities
May 31, 2016 9:00am EDT CohBar, Inc. to Hold 2016 Annual Shareholder Meeting and Investor Update June 14, 2016